Top Markets
Coin of the day
OptiNose, Inc. OptiNose, Inc.

OptiNose, Inc.

OPTN
Kedudukan dalam Saham #9145
OptiNose, Inc. is a specialized pharmaceutical company primarily focused on... OptiNose, Inc. is a specialized pharmaceutical company primarily focused on innovating and bringing to market treatments for individuals under the care of ear, nose, throat, and allergy specialists throughout the United States. Its flagship product, XHANCE, utilizes the company's proprietary exhalation delivery system (EDS) to administer a topically-acting corticosteroid. This therapy is approved for treating chronic rhinosinusitis when accompanied by nasal polyps and is currently undergoing Phase IIIb clinical trials for broader chronic sinusitis treatment. The company also offers Onzetra Xsail, a powder-based EDS device, which is commercialized via a licensing agreement with Currax Pharmaceuticals LLC. Further expanding its pipeline, OptiNose is developing OPN-019, an investigational product that integrates a liquid EDS device with an antiseptic agent. Additionally, OptiNose has formed a partnership with Inexia Limited. This collaboration centers on the development, manufacturing, importation, and sale of products containing orexin receptor agonist or positive modulator molecules, intended for the treatment, diagnosis, or prevention of human conditions predominantly linked to orexin receptor activity. Established in 2000, OptiNose, Inc. operates from its corporate headquarters in Yardley, Pennsylvania.
Harga Saham
$9.60
Disegerakkan terakhir: 2025-05-21
Modal Pasaran
$1.08B
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan OptiNose, Inc. (OPTN)

Kategori

EPS untuk OptiNose, Inc. (OPTN)
EPS setakat March 2025 TTM: $-2.67
Menurut laporan kewangan terkini dan harga saham OptiNose, Inc., EPS semasa syarikat (TTM) adalah $-2.67. Pada akhir tahun 2023, syarikat mempunyai EPS sebanyak $-0.32 penurunan berbanding EPS tahun 2022 iaitu $-13.05.
Sejarah EPS untuk OptiNose, Inc. dari 2015 hingga 2026
EPS pada akhir setiap tahun
Tahun EPS Ubah
2026 (TTM) $-2.67 25.94%
2024 $-2.12 562.50%
2023 $-0.32 -97.55%
2022 $-13.05 806.25%
2021 $-1.44 -29.41%
2020 $-2.04 -21.54%
2019 $-2.60 -2.99%
2018 $-2.68 83.56%
2017 $-1.46 -505.56%
2016 $0.36 -108.39%
2015 $-4.29 0.00%
EPS untuk syarikat atau pesaing yang serupa